Clinical Trial Update: Non-interventional Study With Nab-Paclitaxel (Abraxane®)

View source ↗

Summary

This is a completed non-interventional study evaluating nab-paclitaxel (Abraxane) in patients with metastatic breast cancer. The update indicates completion of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: iOMEDICO AG | Conditions: Metastatic Breast Cancer | Status: COMPLETED